Page 2 - Commercializing Hardtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commercializing hardtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commercializing Hardtech Today - Breaking & Trending Today

UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement. | June 9, 2023 ....

New Jersey , United States , Urogen Pharma Ltd , Urogen Pharma , Urogen Pharma Ltd Stock Exchange , Press Release , F Urgn Il0011407140 ,

Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders

MALVERN, Pa., June 09, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today. | June 9, 2023 ....

Innisfree Ma Incorporated , Ocugen Inc , Exchange Commission , Company Definitive Proxy Statement , Annual Meeting , Definitive Proxy , Definitive Proxy Statement , Private Securities Litigation Reform Act , Nc Stock Exchange , Press Release , Nd Ocgn Us67577c1053 ,

Phathom Pharmaceuticals Announces Closing of Underwriters' Option to Purchase Additional Shares in Connection with Public Offering of Common Stock

FLORHAM PARK, N.J., June 09, 2023 Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced. | June 9, 2023 ....

United States , New York , Nick Benedetto , Evercore Group , Equity Syndicate Prospectus Department , Needham Company , Phathom Pharmaceuticals , Exchange Commission , Phathom Pharmaceuticals Inc , Company Annual Report On Form , Equity Capital Markets , Annual Report , Private Securities Litigation Reform Act , Nc Stock Exchange , Press Release , Astrointestinal Phat Us71722w1071 ,

ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement

ANEW MEDICAL is developing a platform and commercializing novel gene therapies to alleviate and/or reverse the progression of neurodegenerative diseases.ANEW MEDICAL intends to use the proceeds from. | June 6, 2023 ....

United States , New York , Cyruli Shanks , Redwoods Acquisition Corp , Exchange Commission , Redwoods Acquisition , Current Report , United States Securities , Proposed Business Combination , Registration Statement , Redwood Registration Statement , Redwoods Acquisition Corp Stock Exchange , Press Release , Roceeds Rwod Us7580831094 ,

Reata Pharmaceuticals Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

Reata Pharmaceuticals, Inc. , a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that management will. | June 6, 2023 ....

Dana Point , United States , Manmeet Soni , Drug Administration , Reata Pharmaceuticals Inc , Goldman Sachs , Reata Pharmaceuticals , Annual Global Healthcare Conference , Chief Operating Officer , Chief Financial Officer , Nc Stock Exchange , Press Release , Anagement Reta Us75615p1030 ,